Pliva gets first approval for generic EPO
Croatian pharmaceutical company Pliva has won its first European approval for generic erythropoietin, a biologic drug used for the treatment of low red blood cell counts, reports Phil Taylor.
Archives for June 21, 2005
Menopur efficacy recognises infertility drug limitations
Ferring Pharmaceuticals has demonstrated in its latest study with Menopur, resulted in five more pregnancies per 100 women treated, compared to current infertility drug treatments, bringing hope to the 60-80 million couples worldwide affected by...
Gilead initiates HIV integrase inhibitor trial
Gilead Sciences has announced the initiation of phase I/II clinical trial evaluating its latest HIV drug treatment that represents a promising novel class of agents with the potential to inhibit HIV replication, particularly for patients whose HIV has...
Seppic to add colour to BASF's Kollicoat
BASF, the world's largest chemical company, and Seppic, an offshoot of Air Liquide Healthcare, have embarked on a strategic cooperation to jointly develop and market coating systems for film coating of tablets in the drug industry.
Agilent system removes 99 per cent of proteins
Agilent Technologies introduces a high-capacity human protein removal system for proteomics research, that removes up to 99 per cent of the six most common proteins from human blood serum.
Intec delivery tech tackles poor bioavailability
Israeli drug company Intec Pharma has published a results of a clinical trial showing that its drug delivery platform can extend the release of an active ingredient in the upper gastrointestinal tract for more than six hours and double its absorption.
thinXXS packs more into new LOC
Microcomponent manufacturer, thinXXS, has launched a novel microfluidic device which combines microprocessing, micromolding and circuit board technology to integrate more functions than other lab-on-a-chip products on the market today.
LyoCheck from Thermo speeds up biopharma QC
Thermo Electron has launched a new rapid method for the analysis of lyophilised (freeze-dried) materials using ts Nicolet Antaris FT-NIR (Fourier transform near-infrared) analyser.
B-MS looks offshore for bioproduction
US drug major Bristol-Myers Squibb has turned to Celltrion, a company based in South Korea, for the manufacture of biologic drugs, in another example of companies 'offshoring' production to Asia, reports Phil Taylor.
Lexicon and Xoma strike antibody deal
Lexicon Genetics and Xoma have announced the formation of a collaboration to jointly develop and commercialise antibody drugs that could be effective in treating diet-induced obesity and enhanced insulin sensitivity.